Article Details

AzurRx Doses First Two People in Expanded Phase 2b Trial of Cystic Fibrosis Patients

Retrieved on: 2021-01-22 20:48:45

Tags for this article:

Click the tags to see associated articles and topics

AzurRx Doses First Two People in Expanded Phase 2b Trial of Cystic Fibrosis Patients. View article details on hiswai:

Excerpt

AzurRx BioPharma's Chief Medical Officer Dr. James Pennington commented, "As expected, the Data Monitoring Committee (DMC) remains supportive ...

Article found on: www.streetwisereports.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo